Global Oxygen Therapy Market

Oxygen Therapy Comprehensive Study by Application (COPD, Asthma, Sleep Apnea, Respiratory Distress Syndrome (RDS), Cystic Fibrosis, Pneumonia, Other), End-User (Hospitals and Clinics, Home Healthcare, Rehabilitation Centers), Source Equipment (Oxygen Concentrators, Compressed Oxygen Cylinders, Liquid Oxygen Systems), Delivery Devices (Oxygen Masks, Bag Valve Masks, Nasal Cannulas, Venturi Masks, Others) Players and Region - Global Market Outlook to 2026

Oxygen Therapy Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 11.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Oxygen therapy is the administration of oxygen to the patient. Oxygen can be given in a number of ways such as a nasal cannula, inside a hyperbaric chamber, and face mask. It is mostly given in acute conditions, in which tissues such as heart and brain are at risk of oxygen deprivation, and for chronic diseases, which are characterized by sustained low blood oxygen levels. The therapy is given to the patient with breathing disorders and for those who can’t get enough oxygen naturally. The people who receive oxygen therapy often see improved energy levels and sleep, as well as a better quality of life.According to AMA, the market for Oxygen Therapy is expected to register a CAGR of 11.3% during the forecast period to 2026. This growth is primarily driven by Increase in the Prevalence of Breathing Disorders, Favorable Reimbursement Policies around the Globe, The Rising Geriatric Population Worldwide and The Growing Numbers of Hospitals & Clinics Worldwide.

Globally, a noticeable market trend is evident Increasing Use of Oxygen Therapy in Treatment of Diseases Such As COPD, Asthma, Obstructive Sleep Apnea, and Respiratory Distress Syndrome. The Medical Devices sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as 3M (United States), General Electric Company (United States), Koninklijke Philips N.V. (Netherlands), DeVilbiss Healthcare (United States), Essex Industries, Inc. (United States), Fisher & Paykel Healthcare Limited (New Zealand), Inotec AMD Limited (United Kingdom), Invacare Corporation (United States), VitalAire S.A. (South Africa), O2 CONCEPTS, LLC (United States) and Inogen (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On 29 Aug 2018, Philips has expanded its Monitoring & Analytics business with the acquisition of Xhale Assurance Inc. The acquisition is expected to broaden and differentiate Philips’ current portfolio of oxygen saturation monitoring solutions and allow the company to expand into a currently underserved clinical segment.
On 18 Dec 2018, Inogen, Inc. has announced the commercial launch of Inogen Connect. Inogen Connect is a connectivity platform that comprises of a front-end mobile application for use by oxygen therapy users and a back-end database portal for use by home care providers.

Market Drivers
  • Increase in the Prevalence of Breathing Disorders
  • Favorable Reimbursement Policies around the Globe
  • The Rising Geriatric Population Worldwide
  • The Growing Numbers of Hospitals & Clinics Worldwide

Market Trend
  • Increasing Use of Oxygen Therapy in Treatment of Diseases Such As COPD, Asthma, Obstructive Sleep Apnea, and Respiratory Distress Syndrome

Restraints
  • The High Developmental Cost of Advanced Oxygen Therapy Devices
  • Constantly Changing Regulations and Stringent Policies

Opportunities
Increasing Geriatric Population Requiring Home-Based Oxygen Therapy in APAC Region, Rising Healthcare Expenditure of Individuals among Developing Regions and Technological Advancements Made In the Existing Oxygen Delivery Systems

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Oxygen Therapy Study Sheds Light on
— The Oxygen Therapy Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Oxygen Therapy industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Oxygen Therapy industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Application
  • COPD
  • Asthma
  • Sleep Apnea
  • Respiratory Distress Syndrome (RDS)
  • Cystic Fibrosis
  • Pneumonia
  • Other
By End-User
  • Hospitals and Clinics
  • Home Healthcare
  • Rehabilitation Centers

By Source Equipment
  • Oxygen Concentrators
  • Compressed Oxygen Cylinders
  • Liquid Oxygen Systems

By Delivery Devices
  • Oxygen Masks
  • Bag Valve Masks
  • Nasal Cannulas
  • Venturi Masks
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the Prevalence of Breathing Disorders
      • 3.2.2. Favorable Reimbursement Policies around the Globe
      • 3.2.3. The Rising Geriatric Population Worldwide
      • 3.2.4. The Growing Numbers of Hospitals & Clinics Worldwide
    • 3.3. Market Trends
      • 3.3.1. Increasing Use of Oxygen Therapy in Treatment of Diseases Such As COPD, Asthma, Obstructive Sleep Apnea, and Respiratory Distress Syndrome
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Oxygen Therapy, by Application, End-User , Source Equipment , Delivery Devices and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Oxygen Therapy (Value)
      • 5.2.1. Global Oxygen Therapy by: Application (Value)
        • 5.2.1.1. COPD
        • 5.2.1.2. Asthma
        • 5.2.1.3. Sleep Apnea
        • 5.2.1.4. Respiratory Distress Syndrome (RDS)
        • 5.2.1.5. Cystic Fibrosis
        • 5.2.1.6. Pneumonia
        • 5.2.1.7. Other
      • 5.2.2. Global Oxygen Therapy Region
        • 5.2.2.1. South America
          • 5.2.2.1.1. Brazil
          • 5.2.2.1.2. Argentina
          • 5.2.2.1.3. Rest of South America
        • 5.2.2.2. Asia Pacific
          • 5.2.2.2.1. China
          • 5.2.2.2.2. Japan
          • 5.2.2.2.3. India
          • 5.2.2.2.4. South Korea
          • 5.2.2.2.5. Taiwan
          • 5.2.2.2.6. Australia
          • 5.2.2.2.7. Rest of Asia-Pacific
        • 5.2.2.3. Europe
          • 5.2.2.3.1. Germany
          • 5.2.2.3.2. France
          • 5.2.2.3.3. Italy
          • 5.2.2.3.4. United Kingdom
          • 5.2.2.3.5. Netherlands
          • 5.2.2.3.6. Rest of Europe
        • 5.2.2.4. MEA
          • 5.2.2.4.1. Middle East
          • 5.2.2.4.2. Africa
        • 5.2.2.5. North America
          • 5.2.2.5.1. United States
          • 5.2.2.5.2. Canada
          • 5.2.2.5.3. Mexico
  • 6. Oxygen Therapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. 3M (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. General Electric Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Koninklijke Philips N.V. (Netherlands)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. DeVilbiss Healthcare (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Essex Industries, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Fisher & Paykel Healthcare Limited (New Zealand)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Inotec AMD Limited (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Invacare Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. VitalAire S.A. (South Africa)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. O2 CONCEPTS, LLC (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Inogen (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Oxygen Therapy Sale, by Application, End-User , Source Equipment , Delivery Devices and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Oxygen Therapy (Value)
      • 7.2.1. Global Oxygen Therapy by: Application (Value)
        • 7.2.1.1. COPD
        • 7.2.1.2. Asthma
        • 7.2.1.3. Sleep Apnea
        • 7.2.1.4. Respiratory Distress Syndrome (RDS)
        • 7.2.1.5. Cystic Fibrosis
        • 7.2.1.6. Pneumonia
        • 7.2.1.7. Other
      • 7.2.2. Global Oxygen Therapy Region
        • 7.2.2.1. South America
          • 7.2.2.1.1. Brazil
          • 7.2.2.1.2. Argentina
          • 7.2.2.1.3. Rest of South America
        • 7.2.2.2. Asia Pacific
          • 7.2.2.2.1. China
          • 7.2.2.2.2. Japan
          • 7.2.2.2.3. India
          • 7.2.2.2.4. South Korea
          • 7.2.2.2.5. Taiwan
          • 7.2.2.2.6. Australia
          • 7.2.2.2.7. Rest of Asia-Pacific
        • 7.2.2.3. Europe
          • 7.2.2.3.1. Germany
          • 7.2.2.3.2. France
          • 7.2.2.3.3. Italy
          • 7.2.2.3.4. United Kingdom
          • 7.2.2.3.5. Netherlands
          • 7.2.2.3.6. Rest of Europe
        • 7.2.2.4. MEA
          • 7.2.2.4.1. Middle East
          • 7.2.2.4.2. Africa
        • 7.2.2.5. North America
          • 7.2.2.5.1. United States
          • 7.2.2.5.2. Canada
          • 7.2.2.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Oxygen Therapy: by Application(USD Million)
  • Table 2. Oxygen Therapy COPD , by Region USD Million (2015-2020)
  • Table 3. Oxygen Therapy Asthma , by Region USD Million (2015-2020)
  • Table 4. Oxygen Therapy Sleep Apnea , by Region USD Million (2015-2020)
  • Table 5. Oxygen Therapy Respiratory Distress Syndrome (RDS) , by Region USD Million (2015-2020)
  • Table 6. Oxygen Therapy Cystic Fibrosis , by Region USD Million (2015-2020)
  • Table 7. Oxygen Therapy Pneumonia , by Region USD Million (2015-2020)
  • Table 8. Oxygen Therapy Other , by Region USD Million (2015-2020)
  • Table 9. South America Oxygen Therapy, by Country USD Million (2015-2020)
  • Table 10. South America Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 11. South America Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 12. South America Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 13. South America Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 14. Brazil Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 15. Brazil Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 16. Brazil Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 17. Brazil Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 18. Argentina Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 19. Argentina Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 20. Argentina Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 21. Argentina Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 22. Rest of South America Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 23. Rest of South America Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 24. Rest of South America Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 25. Rest of South America Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 26. Asia Pacific Oxygen Therapy, by Country USD Million (2015-2020)
  • Table 27. Asia Pacific Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 28. Asia Pacific Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 29. Asia Pacific Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 30. Asia Pacific Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 31. China Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 32. China Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 33. China Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 34. China Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 35. Japan Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 36. Japan Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 37. Japan Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 38. Japan Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 39. India Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 40. India Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 41. India Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 42. India Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 43. South Korea Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 44. South Korea Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 45. South Korea Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 46. South Korea Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 47. Taiwan Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 48. Taiwan Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 49. Taiwan Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 50. Taiwan Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 51. Australia Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 52. Australia Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 53. Australia Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 54. Australia Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 55. Rest of Asia-Pacific Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 56. Rest of Asia-Pacific Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 57. Rest of Asia-Pacific Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 58. Rest of Asia-Pacific Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 59. Europe Oxygen Therapy, by Country USD Million (2015-2020)
  • Table 60. Europe Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 61. Europe Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 62. Europe Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 63. Europe Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 64. Germany Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 65. Germany Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 66. Germany Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 67. Germany Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 68. France Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 69. France Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 70. France Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 71. France Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 72. Italy Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 73. Italy Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 74. Italy Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 75. Italy Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 76. United Kingdom Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 77. United Kingdom Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 78. United Kingdom Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 79. United Kingdom Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 80. Netherlands Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 81. Netherlands Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 82. Netherlands Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 83. Netherlands Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 84. Rest of Europe Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 85. Rest of Europe Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 86. Rest of Europe Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 87. Rest of Europe Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 88. MEA Oxygen Therapy, by Country USD Million (2015-2020)
  • Table 89. MEA Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 90. MEA Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 91. MEA Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 92. MEA Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 93. Middle East Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 94. Middle East Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 95. Middle East Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 96. Middle East Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 97. Africa Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 98. Africa Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 99. Africa Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 100. Africa Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 101. North America Oxygen Therapy, by Country USD Million (2015-2020)
  • Table 102. North America Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 103. North America Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 104. North America Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 105. North America Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 106. United States Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 107. United States Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 108. United States Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 109. United States Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 110. Canada Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 111. Canada Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 112. Canada Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 113. Canada Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 114. Mexico Oxygen Therapy, by Application USD Million (2015-2020)
  • Table 115. Mexico Oxygen Therapy, by End-User USD Million (2015-2020)
  • Table 116. Mexico Oxygen Therapy, by Source Equipment USD Million (2015-2020)
  • Table 117. Mexico Oxygen Therapy, by Delivery Devices USD Million (2015-2020)
  • Table 118. Company Basic Information, Sales Area and Its Competitors
  • Table 119. Company Basic Information, Sales Area and Its Competitors
  • Table 120. Company Basic Information, Sales Area and Its Competitors
  • Table 121. Company Basic Information, Sales Area and Its Competitors
  • Table 122. Company Basic Information, Sales Area and Its Competitors
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Oxygen Therapy: by Application(USD Million)
  • Table 130. Oxygen Therapy COPD , by Region USD Million (2021-2026)
  • Table 131. Oxygen Therapy Asthma , by Region USD Million (2021-2026)
  • Table 132. Oxygen Therapy Sleep Apnea , by Region USD Million (2021-2026)
  • Table 133. Oxygen Therapy Respiratory Distress Syndrome (RDS) , by Region USD Million (2021-2026)
  • Table 134. Oxygen Therapy Cystic Fibrosis , by Region USD Million (2021-2026)
  • Table 135. Oxygen Therapy Pneumonia , by Region USD Million (2021-2026)
  • Table 136. Oxygen Therapy Other , by Region USD Million (2021-2026)
  • Table 137. South America Oxygen Therapy, by Country USD Million (2021-2026)
  • Table 138. South America Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 139. South America Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 140. South America Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 141. South America Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 142. Brazil Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 143. Brazil Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 144. Brazil Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 145. Brazil Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 146. Argentina Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 147. Argentina Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 148. Argentina Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 149. Argentina Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 150. Rest of South America Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 151. Rest of South America Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 152. Rest of South America Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 153. Rest of South America Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 154. Asia Pacific Oxygen Therapy, by Country USD Million (2021-2026)
  • Table 155. Asia Pacific Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 156. Asia Pacific Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 157. Asia Pacific Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 158. Asia Pacific Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 159. China Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 160. China Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 161. China Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 162. China Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 163. Japan Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 164. Japan Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 165. Japan Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 166. Japan Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 167. India Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 168. India Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 169. India Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 170. India Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 171. South Korea Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 172. South Korea Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 173. South Korea Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 174. South Korea Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 175. Taiwan Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 176. Taiwan Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 177. Taiwan Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 178. Taiwan Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 179. Australia Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 180. Australia Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 181. Australia Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 182. Australia Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 183. Rest of Asia-Pacific Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 184. Rest of Asia-Pacific Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 185. Rest of Asia-Pacific Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 186. Rest of Asia-Pacific Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 187. Europe Oxygen Therapy, by Country USD Million (2021-2026)
  • Table 188. Europe Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 189. Europe Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 190. Europe Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 191. Europe Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 192. Germany Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 193. Germany Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 194. Germany Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 195. Germany Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 196. France Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 197. France Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 198. France Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 199. France Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 200. Italy Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 201. Italy Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 202. Italy Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 203. Italy Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 204. United Kingdom Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 205. United Kingdom Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 206. United Kingdom Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 207. United Kingdom Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 208. Netherlands Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 209. Netherlands Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 210. Netherlands Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 211. Netherlands Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 212. Rest of Europe Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 213. Rest of Europe Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 214. Rest of Europe Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 215. Rest of Europe Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 216. MEA Oxygen Therapy, by Country USD Million (2021-2026)
  • Table 217. MEA Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 218. MEA Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 219. MEA Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 220. MEA Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 221. Middle East Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 222. Middle East Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 223. Middle East Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 224. Middle East Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 225. Africa Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 226. Africa Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 227. Africa Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 228. Africa Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 229. North America Oxygen Therapy, by Country USD Million (2021-2026)
  • Table 230. North America Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 231. North America Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 232. North America Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 233. North America Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 234. United States Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 235. United States Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 236. United States Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 237. United States Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 238. Canada Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 239. Canada Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 240. Canada Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 241. Canada Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 242. Mexico Oxygen Therapy, by Application USD Million (2021-2026)
  • Table 243. Mexico Oxygen Therapy, by End-User USD Million (2021-2026)
  • Table 244. Mexico Oxygen Therapy, by Source Equipment USD Million (2021-2026)
  • Table 245. Mexico Oxygen Therapy, by Delivery Devices USD Million (2021-2026)
  • Table 246. Research Programs/Design for This Report
  • Table 247. Key Data Information from Secondary Sources
  • Table 248. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Oxygen Therapy: by Application USD Million (2015-2020)
  • Figure 5. South America Oxygen Therapy Share (%), by Country
  • Figure 6. Asia Pacific Oxygen Therapy Share (%), by Country
  • Figure 7. Europe Oxygen Therapy Share (%), by Country
  • Figure 8. MEA Oxygen Therapy Share (%), by Country
  • Figure 9. North America Oxygen Therapy Share (%), by Country
  • Figure 10. Global Oxygen Therapy share by Players 2020 (%)
  • Figure 11. Global Oxygen Therapy share by Players (Top 3) 2020(%)
  • Figure 12. Global Oxygen Therapy share by Players (Top 5) 2020(%)
  • Figure 13. BCG Matrix for key Companies
  • Figure 14. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 15. 3M (United States) Revenue: by Geography 2020
  • Figure 16. General Electric Company (United States) Revenue, Net Income and Gross profit
  • Figure 17. General Electric Company (United States) Revenue: by Geography 2020
  • Figure 18. Koninklijke Philips N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 19. Koninklijke Philips N.V. (Netherlands) Revenue: by Geography 2020
  • Figure 20. DeVilbiss Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 21. DeVilbiss Healthcare (United States) Revenue: by Geography 2020
  • Figure 22. Essex Industries, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Essex Industries, Inc. (United States) Revenue: by Geography 2020
  • Figure 24. Fisher & Paykel Healthcare Limited (New Zealand) Revenue, Net Income and Gross profit
  • Figure 25. Fisher & Paykel Healthcare Limited (New Zealand) Revenue: by Geography 2020
  • Figure 26. Inotec AMD Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. Inotec AMD Limited (United Kingdom) Revenue: by Geography 2020
  • Figure 28. Invacare Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 29. Invacare Corporation (United States) Revenue: by Geography 2020
  • Figure 30. VitalAire S.A. (South Africa) Revenue, Net Income and Gross profit
  • Figure 31. VitalAire S.A. (South Africa) Revenue: by Geography 2020
  • Figure 32. O2 CONCEPTS, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 33. O2 CONCEPTS, LLC (United States) Revenue: by Geography 2020
  • Figure 34. Inogen (United States) Revenue, Net Income and Gross profit
  • Figure 35. Inogen (United States) Revenue: by Geography 2020
  • Figure 36. Global Oxygen Therapy: by Application USD Million (2021-2026)
  • Figure 37. South America Oxygen Therapy Share (%), by Country
  • Figure 38. Asia Pacific Oxygen Therapy Share (%), by Country
  • Figure 39. Europe Oxygen Therapy Share (%), by Country
  • Figure 40. MEA Oxygen Therapy Share (%), by Country
  • Figure 41. North America Oxygen Therapy Share (%), by Country
List of companies from research coverage that are profiled in the study
  • 3M (United States)
  • General Electric Company (United States)
  • Koninklijke Philips N.V. (Netherlands)
  • DeVilbiss Healthcare (United States)
  • Essex Industries, Inc. (United States)
  • Fisher & Paykel Healthcare Limited (New Zealand)
  • Inotec AMD Limited (United Kingdom)
  • Invacare Corporation (United States)
  • VitalAire S.A. (South Africa)
  • O2 CONCEPTS, LLC (United States)
  • Inogen (United States)
Additional players considered in the study are as follows:
OxyBand Technologies, Inc. (United States) , Nidek Medical Products Inc. (United States) , MAQUET Holding B.V. & Co. KG. (Germany)
Select User Access Type

Key Highlights of Report


Jul 2021 150 Pages 57 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Oxygen Therapy Market Quantitative research analysis
Global Oxygen Therapy Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Oxygen Therapy market is expected to see a CAGR of 11.3% during projected year 2020 to 2026.
Top performing companies in the Global Oxygen Therapy market are 3M (United States), General Electric Company (United States), Koninklijke Philips N.V. (Netherlands), DeVilbiss Healthcare (United States), Essex Industries, Inc. (United States), Fisher & Paykel Healthcare Limited (New Zealand), Inotec AMD Limited (United Kingdom), Invacare Corporation (United States), VitalAire S.A. (South Africa), O2 CONCEPTS, LLC (United States) and Inogen (United States), to name a few.
North America is dominating the Oxygen Therapy Market.

Know More About Global Oxygen Therapy Market Report?

Have a Query? Click Here

Other Related Reports

Vein Finders Comprehensive Study by Type (Non-Imaging Type Vein Finder, Portable Type Vein Finder, Fixed Type Vein Finder, Wearable Type Vein Finder), Application (Blood Draw/Venipuncture, IV Access,...
$ 3650
Wearable EEG Device Comprehensive Study by Type (Battery, Charge), Channel (32-channel Type, 14-channel Type, 5-channel Type, Others), Disease (TBI, Stroke, Dementia, Epilepsy, Headache,, Sleep), En...
$ 3350
Blood Collection Monitor Comprehensive Study by Battery Backup (Upto 4 Hrs, 5 Hrs – 6 Hrs, 7 Hrs – 8 Hrs, 9 Hrs – 10 Hrs, More Than 10 Hrs), End-Users (Hospitals, Pathology Laboratories, Blood Banks,...
$ 3650
Bipolar Coagulation Forcep Comprehensive Study by Type (Irrigating, Non-irrigating, Disposable), Application (Hospital, Medical Research Organization), Insulation (Insulated, Non-Insulated), Shape (S...
$ 3450
Syringe Rubber Stopper Comprehensive Study by Type (Threaded, Non- Threaded), Application (Pharmaceutical, Laboratory), Distribution Channel (Online, OEMs, Specialty Stores, Others), Syringe Type (No...
$ 3750
Veterinary Anesthesia Machine Comprehensive Study by Type (On Trolley Anesthesia Machines, Portable Anesthesia Machines), Application (For Small Animals, For Large Animals) Players and Region - Globa...
$ 3500